Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults

Completed · Phase 4

Conditions studied: Epilepsy

In brief

Double-blind, randomized, two period crossover comparison of the cognitive and behavioral effects of Eslicarbazepine acetate and Carbamazepine in healthy volunteers.

Key facts

Study ID

NCT02912364

Run by

Stanford University

People needed

46

Starts

2016-07-01

Expected to finish

2018-04-20

Last updated by the study team

2019-06-04

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adults between the ages of 18 and 55 years old.
• Male or female

You may not qualify if…

• Presence of clinically significant cardiovascular, endocrine, hematopoietic, hepatic, neurologic, psychiatric, or renal disease or pregnancy.
• Presence or history of drug or alcohol abuse.
• The use of concomitant medications, which are known to affect ESL or Carbamazepine or the use of any concomitant medications that may alter cognitive function (see Section VII.E for a partial list).
• Use of oral contraceptive hormones or other medications that could be affected by ESL or Carbamazepine.
• Prior adverse reaction to or prior hypersensitivity to either study medication or to related compounds.
• Prior participation in studies involving anticonvulsant medications.
• Subjects who have received any investigational drug within the previous thirty days.
• Subjects with IQ < 70 as determined by the Peabody Picture Vocabulary Test.
• Presence of HLA B*1502 in subjects of Asian descent; this will be obtained at screening in subjects of Asian descent.

Where it is running

• Stanford University — Palo Alto, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.